Purchase Order 36C24425P0005

Award Date 10/1/24
Potential Completion Date 9/30/25
Potential Value $148K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Wilkes-Barre, PA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $88,774.26, was issued by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The contract is for the delivery of radiopharmaceuticals to support nuclear medicine diagnostic imaging and treatment procedures for veterans. Jubilant Radiopharma is a for-profit organization that specializes in manufacturing, distributing, and...
This federal contract award, valued at $184,507.80, was issued by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The contract is for the delivery of radiopharmaceuticals, which are specialized medical isotopes and imaging agents used in nuclear medicine procedures to support diagnostic imaging and cancer treatment services for veterans. Jubilant Radiopharma is a for-profit, self-certified small disadvantaged...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $93,446.62 firm fixed-price delivery order contract to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business. This contract is to provide radiopharmaceuticals supporting nuclear medicine services and procedures for veterans at VA medical facilities. Jubilant Radiopharma has held multiple indefinite delivery contracts and blanket purchase...
The U.S. Department of Veterans Affairs (VA) awarded a $150,000.00 firm-fixed-price delivery order to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a for-profit small disadvantaged business, for the supply of nuclear medicine radiopharmaceuticals. This delivery order is part of a larger Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA) with the VA's Veterans Integrated Service Network (VISN) 10, which covers the supply of specialized...
This federal contract, valued at $439,477.00, was awarded to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit organization and self-certified small disadvantaged business. The contract, awarded by the Department of Veterans Affairs (VA) through its Veterans Integrated Service Network (VISN) 15, is for the supply of radiopharmaceuticals, including medical isotopes, diagnostic imaging agents, and therapeutic radioisotopes, to support nuclear medicine...
The Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the supply of radiopharmaceuticals. The $740,177.94 contract is part of a larger $39.8 million multiple-award Indefinite Delivery Contract (IDC) with the VA's Network Contracting Office 8, as well as additional IDVs with the VA and Defense Health Agency (DHA) worth up...
This federal contract award, valued at $83,454.67, was issued by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a self-certified small disadvantaged business. The contract is for the delivery of radiopharmaceuticals, which are specialized nuclear medicine products used in diagnostic imaging and treatment procedures for veterans and military personnel. The contract is a delivery order under a larger Indefinite...
This federal contract award to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma) is for the supply of nuclear medicine imaging radio-therapeutic isotopes to the Department of Veterans Affairs (VA). The $843,077.64 firm-fixed-price delivery order contract has a performance period extending through February 28, 2026. Jubilant Radiopharma, a for-profit small disadvantaged business, specializes in manufacturing, distributing, and supplying radiopharmaceuticals and...
This federal contract award, valued at $456,032.74, was issued by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, on October 1, 2024. The contract is a firm-fixed-price delivery order under an Indefinite Delivery Contract (IDC) or Blanket Purchase Agreement (BPA) with the VA, with a performance period through September 30, 2025. Jubilant Radiopharma, a for-profit organization and self-certified small...
This federal contract award is for RADIOPHARMACEUTICALS, awarded to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The contract, valued at $929,720.00, was awarded on October 1, 2024 by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 8 (VISN 8). Jubilant Radiopharma is a key supplier of radiopharmaceuticals and nuclear medicine products to the VA, supporting its healthcare services for veterans across the country....

This federal contract award was issued by the Veterans Integrated Service Network 4 (VISN 4), a component of the U.S. Department of Veterans Affairs (VA), to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The $148,434.08 firm fixed-price purchase order is for the provision of radiopharmaceuticals, including Ga-68 Dotatate, gallium-based diagnostic imaging agents, iodine I-123, and various therapeutic radioisotopes. This contract supports the VA's medical services and procedures for veterans, such as positron emission tomography (PET) scans, cardiac imaging, and cancer treatment. Jubilant Radiopharma is a key supplier of these critical nuclear medicine products to the VA, and this award is part of the company's broader portfolio of Indefinite Delivery Vehicles (IDVs) with the agency, valued up to $39.8 million. The contract does not have a set-aside designation, but Jubilant Radiopharma is self-certified as a small disadvantaged business.

Generated 10/2/24, 10:24 AM